PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F0CAE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $10,331
Award facts
- Contract value 100% obligated
- $10,330.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,330.72 on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price contract, which carries no set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain and represents a child order under the company's larger pharmaceutical supply vehicle. The delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
The contract reflects AmerisourceBergen's established role as a critical vendor for federal medical procurement, particularly for Defense Health Agency and military healthcare systems. Under its prime IDC vehicle, the company supplies an extensive portfolio including brand-name and generic medications, specialty pharmaceuticals, vaccines, medical devices, and related healthcare commodities across multiple therapeutic domains. All of AmerisourceBergen's federal contract awards, including this delivery order, have been competitively awarded without set-aside designations, demonstrating the company's capability to meet federal procurement requirements in open competition. The Defense Logistics Agency is planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, representing a strategic approach to pharmaceutical support for military and federal healthcare systems.
Quick answers
Who was awarded contract SPE2D826F0CAE?
SPE2D826F0CAE was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on December 8, 2025.
How much is contract SPE2D826F0CAE worth?
The government has obligated $10,331 on SPE2D826F0CAE.
Is contract SPE2D826F0CAE an order under another contract?
Yes. SPE2D826F0CAE is a delivery order under SPE2DX22D0129, an indefinite delivery contract.
Was contract SPE2D826F0CAE competed?
The extent of competition for SPE2D826F0CAE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award